China Pharma shareholders approve reverse stock split at 1:10–1:20; all directors elected

CHINA PHARMA HOLDINGS, INC.

All five director nominees elected: Zhilin Li, Heung Mei Tsui (non-independent), Gene Michael Bennett, Yingwen Zhang, Baowen Dong (independent).
Amendment to allow reverse stock split at ratio between 1:10 and 1:20 approved; board retains discretion to effect.
Amendment No.2 to the 2010 Long-Term Incentive Plan approved by shareholders.
Advisory vote on executive compensation approved; frequency set at every three years.
Annual meeting held Dec 22, 2024; quorum of ~52% (9,688,133 shares) of outstanding stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.